EP Medsystems (MM) News - EPMD

FeaturedSouthern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project

EP MedSystems Announces $10.0 Million Equity Financing

EP MedSystems, Inc. (NASDAQ: EPMD), a market leader in electrophysiology products used in cardiac rhythm management, today announced that it has...

EP MedSystems Announces Release Date and Conference Call Time for Fourth Quarter 2005 Financial Results

WEST BERLIN, N.J., March 20 /PRNewswire-FirstCall/ -- EP MedSystems, Inc. (NASDAQ:EPMD), a market leader in electrophysiology products used to...

EP MedSystems Reports Third Quarter and Nine Month Results

EP MedSystems, Inc. (NASDAQ: EPMD), a market leader in electrophysiology products used to diagnose and treat certain types of cardiac rhythm...

EP MedSystems Invites You to Join Its Third Quarter Conference Call On November 10, 2005

EP MedSystems, Inc. (Nasdaq:EPMD) invites you to participate in a teleconference call to discuss third quarter results on November 10th at 4:30...

EP MedSystems to Present to Investors at the Rodman & Renshaw 7th Annual Techvest Healthcare Conference

Executives to Convey Company Market Positioning and Growth Strategies WEST BERLIN, N.J., Nov. 4 /PRNewswire-FirstCall/ -- EP MedSystems, Inc...

EP MedSystems to Present to Investors at C.E. Unterberg, Towbin Life Sciences Conference; Executives to Convey Company Market Po

EP MedSystems, Inc. (NASDAQ: EPMD), a market leader in electrophysiology products used in cardiac rhythm management, has been invited to present...

Additional Information Pertaining to Change of Chief Executive Officer

Earlier today, EP MedSystems, Inc. (Nasdaq: EPMD), announced that its Board of Directors had terminated Reinhard Schmidt's employment as its...

EP MedSystems Announces Change in Chief Executive Officer

EP MedSystems, Inc. (Nasdaq: EPMD), today announced that its Board of Directors had terminated Reinhard Schmidt's employment as its President...

EP MedSystems Announces Canadian Regulatory Clearance for EP-4 Computerized Cardiac Stimulator

EP MedSystems, Inc. (NASDAQ: EPMD), a market leader in electrophysiology products used in cardiac rhythm management, today announced Health Canada...

EP MedSystems - Clarification

EP MedSystems, Inc. (Nasdaq: EPMD). Yesterday afternoon, EP MedSystems, Inc. held its Second Quarter 2005 Conference Call. Among the topics...

EP MedSystems Reports Record Second Quarter Revenues; Revenues Increase 33% Year-Over-Year & 37% Over First Quarter 2005

EP MedSystems, Inc. (NASDAQ: EPMD), a market leader in electrophysiology products used to diagnose and treat certain types of cardiac rhythm...

EP MedSystems Invites You to Join Its Second Quarter Conference Call On August 11, 2005

EP MedSystems, Inc. (Nasdaq: EPMD) invites you to participate in a teleconference call to discuss second quarter results on August 11th at 4:30...

EP MedSystems to Present to Investors at the C.E. Unterberg, Towbin Emerging Growth Investor Conference; Executives to Convey Co

EP MedSystems, Inc. (NASDAQ: EPMD), a market leader in electrophysiology products used in cardiac rhythm management, has been invited to present...

EP MedSystems Files with FDA to Expand ALERT Product Line for Use in All EP Diagnostic Procedures

EP MedSystems, Inc. (NASDAQ: EPMD) today announced its intention to expand the market for its ALERT(R) product platform with the submission of the...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

EP Medsystems (MM) (EPMD)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

EPMD News

FeaturedSouthern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project

EP MedSystems Announces $10.0 Million Equity Financing

EP MedSystems Announces Release Date and Conference Call Time for Fourth Quarter 2005 Financial Results

EP MedSystems Reports Third Quarter and Nine Month Results

EP MedSystems Invites You to Join Its Third Quarter Conference Call On November 10, 2005

EP MedSystems to Present to Investors at the Rodman & Renshaw 7th Annual Techvest Healthcare Conference

EP MedSystems to Present to Investors at C.E. Unterberg, Towbin Life Sciences Conference; Executives to Convey Company Market Po

Additional Information Pertaining to Change of Chief Executive Officer

EP MedSystems Announces Change in Chief Executive Officer

EP MedSystems Announces Canadian Regulatory Clearance for EP-4 Computerized Cardiac Stimulator

EP MedSystems - Clarification

EP MedSystems Reports Record Second Quarter Revenues; Revenues Increase 33% Year-Over-Year & 37% Over First Quarter 2005

EP MedSystems Invites You to Join Its Second Quarter Conference Call On August 11, 2005

EP MedSystems to Present to Investors at the C.E. Unterberg, Towbin Emerging Growth Investor Conference; Executives to Convey Co

EP MedSystems Files with FDA to Expand ALERT Product Line for Use in All EP Diagnostic Procedures

EPMD Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

EP Medsystems (MM) (EPMD) News

EP Medsystems (MM) (EPMD)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

EPMD News

FeaturedSouthern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project

EP MedSystems Announces $10.0 Million Equity Financing

EP MedSystems Announces Release Date and Conference Call Time for Fourth Quarter 2005 Financial Results

EP MedSystems Reports Third Quarter and Nine Month Results

EP MedSystems Invites You to Join Its Third Quarter Conference Call On November 10, 2005

EP MedSystems to Present to Investors at the Rodman & Renshaw 7th Annual Techvest Healthcare Conference

EP MedSystems to Present to Investors at C.E. Unterberg, Towbin Life Sciences Conference; Executives to Convey Company Market Po

Additional Information Pertaining to Change of Chief Executive Officer

EP MedSystems Announces Change in Chief Executive Officer

EP MedSystems Announces Canadian Regulatory Clearance for EP-4 Computerized Cardiac Stimulator

EP MedSystems - Clarification

EP MedSystems Reports Record Second Quarter Revenues; Revenues Increase 33% Year-Over-Year & 37% Over First Quarter 2005

EP MedSystems Invites You to Join Its Second Quarter Conference Call On August 11, 2005

EP MedSystems to Present to Investors at the C.E. Unterberg, Towbin Emerging Growth Investor Conference; Executives to Convey Co

EP MedSystems Files with FDA to Expand ALERT Product Line for Use in All EP Diagnostic Procedures

EPMD Discussion

Your Recent History